GILEAD SCIENCES, INC. — Director's Dealing 2018

Feb 16, 2018

SEC Form 5 — Annual Statement of Changes in Beneficial Ownership

Issuer: GILEAD SCIENCES INC (GILD)
CIK: 0000882095
Period of Report: 2017-12-31

Reporting Person: Alton Gregg H (EVP,Corporate &Medical Affairs)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-01-20	Common Stock	W	14435	$71.01	Acquired	14435	Indirect

Footnotes

F1: Shares inherited from family trust